Laxmi Tiwari | Medicinal Chemistry | Best Researcher Award

Posted on by sciencefather

Dr. Laxmi Tiwari | Medicinal Chemistry | Best Researcher Award

Icahn School of Medicine at Mount Sinai, United States

Author Profiles

Scopus

Orcid

Google Scholar

🎓 Educational Background

Dr. Laxmi Tiwari is currently completing her Ph.D. in Chemistry with an impressive GPA of 3.98 at the University of Idaho, Moscow, ID (Aug 2021 – Dec 2024), under the mentorship of Assoc. Prof. Dr. Kristopher V. Waynant. Her research focuses on the “Synthesis and Applications of Azothioformamide and Azoformamide Ligands in Coordination, Catalysis, and Biological Activity.” She earned her M.S. in Chemistry from Tribhuvan University, Kathmandu, Nepal (May 2017 – July 2019), and completed her B.S. in Chemistry from the same institution (Aug 2012 – July 2016), laying a strong academic foundation in chemical sciences.

🧪 Professional Experience

Dr. Tiwari began her postdoctoral journey as a Research Assistant Scientist in January 2025 at the Pharmacological Department, Icahn School of Medicine at Mount Sinai, NY, under the guidance of Prof. Dr. Robert J. DeVita. Here, she is involved in designing and synthesizing organic molecules targeting diseases such as IBD, cancer, and diabetes. Her responsibilities include conducting clinical research, computational modeling, and developing new methodologies and instrumentation for medical applications. She actively contributes to research through hypothesis development, data evaluation, and publishing scientific findings, all while ensuring strict safety and contamination protocols are maintained. Previously, she served as a Graduate Research and Teaching Assistant at the University of Idaho (Aug 2021 – Dec 2024). Her work included retrosynthetic design, metal-ligand complex formation, and the development of palladium-catalyzed C–C and C–N coupling reactions. She also led efforts in drug synthesis, SAR analysis, and fluorescence sensing using heteroleptic cuprous complexes. She played a key role in student training, lab safety compliance, and instruction of both general and organic chemistry courses, including CHEM 101, 111, 112, 278, and 378.

🧠 Technical Skills & Expertise

Dr. Tiwari possesses advanced instrumentation skills, including NMR (1D & 2D), FT-IR, Mass Spectrometry, UV-Vis, SEM, and electrochemistry. She is proficient with software tools like ChemDraw, Topspin, Mnova, Schrodinger-Maestro, SwissADME, and AutoDock Vina. Her lab expertise includes flash column chromatography, crystallization, hazardous waste management, and more. She is also recognized for her problem-solving abilities, analytical thinking, communication skills, and attention to detail, all essential traits for thriving in complex research environments.

🏆 Awards & Honors

Dr. Tiwari has been honored with several prestigious awards including the ACS DIC Travel Award (Fall 2023), GPSA Travel Awards (2023 & 2024) from the University of Idaho, the Thomas F. Howland Award (2024), and the Cooley-Jube Outstanding TA Award (2024–2025). These recognitions reflect her academic excellence, research contributions, and dedication to teaching.

👩‍🔬 Professional Membership

She is an active member of the American Chemical Society (ACS) since 2021, which underscores her commitment to professional development and collaborative scientific advancement.

Notable Publications📝

📝Exploring Photocatalytic, Antimicrobial and Antioxidant Efficacy of Green-Synthesized Zinc Oxide Nanoparticles

Authors: Sabina Shrestha, Laxmi Tiwari, Sujan Dhungana, Jasana Maharjan, Devendra Khadka, Allison A. Kim, Megh Raj Pokhrel, Janaki Baral, Mira Park, Bhoj Raj Poudel

Journal: Nanomaterials

Year: 2025

📝Exploring the Electronic Influence on Coordination Complexes Formed from Appended Pyrrolidine Azothioformamide Ligands and Copper(I) Salts

Authors: Laxmi Tiwari, Zachariah M. Heiden, Kristopher V. Waynant

Journal: Journal of Molecular Structure

Year: 2025

📝Green Synthesis of Copper Oxide Nanoparticles Using Mentha (Mint) Leaves Characterization and Its Antimicrobial Properties with Phytochemicals Screening

Authors: Janaki Baral, Neena Pokharel, Sujan Dhungana, Laxmi Tiwari, Devendra Khadka, Megh Raj Pokhrel, Bhoj Raj Poudel

Journal: Journal of Nepal Chemical Society

Year: 2025

📝Synthesis and Characterization of Copper Oxide Nanoparticles Isolated from Acmella oleracea and Study of Antimicrobial and Phytochemical Properties

Authors: Sujan Dhungana, Anusa Gauli, Laxmi Tiwari, Devendra Khadka, Surendra Kumar Gautam, Megh Raj Pokhrel, Janaki Baral, Bhoj Raj Poudel

Journal: Amrit Research Journal

Year: 2024

📝Investigating Arylazoformamide Ligands in Palladium(II) Precatalysts through the Suzuki–Miyaura Cross-Coupling Reaction

Authors: Laxmi Tiwari, Elliott B. Hulley, Kristopher V. Waynant

Journal: The Journal of Organic Chemistry

Year: 2024

 

Dr. Ziaurrehman Tanoli – Drug repurposing – Best Researcher Award

Posted on by sciencefather

Dr. Ziaurrehman Tanoli – Drug repurposing – Best Researcher Award

University of Helsinki, Finland

Author Profiles

Google Scholar

Orcid

🎓Educational Background 

Dr. Tanoli completed his MS leading to PhD in Machine Learning at PIEAS and holds a Bachelor’s in Computer and Information Sciences from the same institution. In 2022, he was awarded the title of Docent in Pharmaceutical Chemistry by the University of Helsinki.

🏢Work Experience 

Dr. Tanoli has an extensive academic background, with experience in several prestigious institutions. Currently, he holds a position as a Senior Researcher at FIMM, and has previously served as an Associate Professor at the University of Helsinki. His prior roles include postdoctoral positions at FIMM, University of Helsinki, and the University of Sannio, Italy. He has also served as an Assistant Professor at COMSATS University Islamabad in Pakistan.

🏆Achievements 

Dr. Ziaurrehman Tanoli has established himself as an exceptional scientist, completing his PhD at the age of 27. His research has been widely recognized, with one of his most significant accomplishments being the publication of an article as the first author in Nature Reviews Drug Discovery (Impact Factor: 122). He co-organized the IDG-DREAM challenge, which was featured in Nature Communications in 2021. Dr. Tanoli also made notable strides in research challenges, such as winning the CTD2Pancancer Drug Activity Dream Challenge (CRM, 2022) and the CTD2Pancancer Chemosensitivity Dream Challenge (publication pending). His grant funding achievements include securing the AoF Project Funding (2022–2026) for €0.58M to support his project on drug repurposing and receiving a Young Researchers Grant (2023) from the Aaltonen Foundation for €37K. Furthermore, he has been awarded the MSCA SE EU Mobility Grant for €29K for the years 2025-2028.

🔬Research Expertise 

Dr. Tanoli specializes in AI-driven drug discovery, focusing on a variety of areas such as attention-based models, large language models, and generative AI for software development. His expertise extends to target-based drug discovery and repurposing, where he developed methods for predicting drug-target interactions across 7 protein superfamilies. He has also made significant contributions to phenotypic drug discovery, including multi-omics-based drug response prediction and synergistic drug combination identification. Dr. Tanoli has published 27 articles in the last five years, with 13 of them as corresponding or first author. His work has also expanded into the development of drug repurposing pipelines and drug safety analysis models.

💡Research Grants & Projects 

Throughout his career, Dr. Tanoli has secured numerous research grants and project funding for innovative drug discovery solutions. His projects span topics such as drug repurposing, AI models for drug discovery, and multi-omics analysis. The AoF Project (2022-2026) received €0.58M, and his other prestigious projects include the REMEDI4ALL EU Project (2022-2027) and EOSC-Life EU Project (2019-2023).

👩‍🏫Teaching & Supervision 

With over 300 contact hours of teaching, Dr. Tanoli has actively contributed to educational development. He has taught various topics related to pharmaceutical chemistry, machine learning, and bioinformatics. His dedication to mentorship is also evident through his supervision of 3 PhD students, 4 research assistants, 2 software developers, and 1 postdoc.

Notable Publications📝

📝Computational drug repurposing: approaches, evaluation of in silico resources and case studies

    • Authors: Ziaurrehman Tanoli, Adrià Fernández-Torras, Umut Onur Özcan, Aleksandr Kushnir, Kristen Michelle Nader, Yojana Gadiya, Laura Fiorenza, Aleksandr Ianevski, Markus Vähä-Koskela, Mitro Miihkinen et al.

    • Journal: Nature Reviews Drug Discovery

    • Year: 2025

📝Validation guidelines for drug-target prediction methods

    • Authors: Ziaurrehman Tanoli, Aron Schulman, Tero Aittokallio

    • Journal: Expert Opinion on Drug Discovery

    • Year: 2025

📝Machine Learning and Artificial Intelligence in Drug Repurposing—Challenges and Perspectives

    • Authors: Ezequiel Anokian, Judith Bernett, Adrian Freeman, Markus List, Lucía Prieto Santamaría, Ziaurrehman Tanoli, Sarah Bonnin

    • Journal: Drug Repurposing

    • Year: 2024

📝PGxDB: An interactive web-platform for pharmacogenomics research

    • Authors: Trinh Trung Duong Nguyen, Ziaurrehman Tanoli, Saad Hassan, Umut Özcan, Jimmy Caroli, Albert Kooistra, David Gloriam, Alexander Hauser

    • Journal: Nucleic Acids Research

    • Year: 2024

📝Attention-based approach to predict drug–target interactions across seven target superfamilies

    • Authors: Aron Schulman, Juho Rousu, Tero Aittokallio, Ziaurrehman Tanoli, Xin Gao

    • Journal: Bioinformatics

    • Year: 2024

 

Mrs. Fatemeh Jahanmard – Pharmaceutical Chemistry – Best Researcher Award

Posted on by sciencefather

Mrs. Fatemeh Jahanmard – Pharmaceutical Chemistry – Best Researcher Award

Gilbert – Netherlands

Author Profile

Scopus

Google Scholar

🎓 Academic Background & Expertise

Mrs. Fatemeh Jahanmard Hosseinabadi holds a Ph.D. in Nanotechnology, specializing in formulation development, materials characterization, and drug delivery systems. With extensive expertise in these areas, she has contributed significantly to the advancement of polymeric and lipid-based nano/microparticles, antibacterial coatings, and hydrogel formulations for controlled drug release.

🔬 Postdoctoral Research & Scientific Contributions

She pursued four years of postdoctoral research at Utrecht University, where she developed advanced hydrogel coatings and nanoparticle-based drug delivery systems. Her work focused on innovative materials for biomedical applications, leading to the development of cutting-edge drug delivery platforms. During this time, she also mentored over ten graduate students, led multiple research projects, and managed laboratory operations, showcasing her leadership in academia.

🏥 Industry Leadership & Innovation

Currently serving as an R&D Manager at EHDA and Formulation Scientist at Gilbert, she plays a crucial role in bridging academia and industry. Her expertise in medical devices, biomaterials, coatings, and formulation science has been instrumental in driving innovative formulation strategies. In the industry, she has successfully established a formulation and test development lab, optimized drug delivery systems, and collaborated with engineers, scientists, professors, and regulatory experts to develop a novel inhaler device.

🏆 Bridging Academia & Industry

Her career is defined by her ability to translate research insights into practical applications, fostering innovation in formulation science. By integrating knowledge from both academic research and industrial applications, she continues to drive groundbreaking advancements in drug delivery systems, medical devices, and biomaterial coatings.

Notable Publications📝

📝Layer by Layer Coating for Bio-functionalization of Additively Manufactured Meta-Biomaterials

Authors: S Amin Yavari, M Croes, B Akhavan, F Jahanmard, CC Eigenhuis, Sasan Dadbakhsh, HC Vogely, MM Bilek, AC Fluit, CHE Boel, BCH Van Der Wal, T Vermonden, H Weinans, AA Zadpoor

Journal: Additive Manufacturing

Year: 2020

📝Bactericidal Coating to Prevent Early and Delayed Implant-Related Infections

Authors: F Jahanmard, M Croes, M Castilho, A Majed, MJ Steenbergen, K Lietaert, HC Vogely, BCH Van Der Wal, DAC Stapels, J Malda, T Vermonden, S Amin Yavari

Journal: Journal of Controlled Release

Year: 2020

📝Effect of Nanoporous Fibers on Growth and Proliferation of Cells on Electrospun Poly (ϵ-Caprolactone) Scaffolds

Authors: Fatemeh Jahanmard Hossein Abadi, Mohammad Amani Tehran, Fatemeh Zamani, Marziyeh Nematollahi, Laleh Ghasemi Mobarakeh, Mohammad Hossein Nasr-Esfahani

Journal: International Journal of Polymeric Materials and Polymeric Biomaterials

Year: 2014

📝Controlled Temperature-Mediated Curcumin Release from Magneto-Thermal Nanocarriers to Kill Bone Tumors

Authors: A Khodaei, F Jahanmard, HR Madaah Hosseini, R Bagheri, A Dabbagh, H Weinans, S Amin Yavari

Journal: Bioactive Materials

Year: 2022

📝A Multifunctional Silk Coating on Additively Manufactured Porous Titanium to Prevent Implant-Associated Infection and Stimulate Bone Regeneration

Authors: Z Gorgin Karaji, F Jahanmard, AH Mirzaei, B Van der Wal, S Amin Yavari

Journal: Biomedical Materials

Year: 2020

 

Dr. Aloïse Mabondzo | drug design | Best Researcher Award

Posted on by sciencefather

Dr. Aloïse Mabondzo | drug design | Best Researcher Award

Doctorate at CEA, France

Professional Profiles

Google Scholar

Scopus

Orcid

🎓 Educational Background

Dr. Aloïse Mabondzo, has a distinguished academic foundation. He earned his Master’s degree in Molecular and Cellular Biology from the University of Strasbourg, France (1986-1989). Driven by a passion for cutting-edge research, he pursued a PhD in Virology and Immunology at the prestigious Pierre and Marie Curie University, France (1989-1993). His doctoral work focused on Active Immunotherapy using bispecific antibodies against HIV, a testament to his early commitment to tackling global health challenges.

🧪 Professional Positions

Dr. Mabondzo’s illustrious career began with a Post-doctoral Research Fellowship (1993-1997) at the CEA Neurovirology Department, where he made significant contributions to the field of neurovirology. In 1998, he joined the CEA Medicine and Healthcare Technologies Department, where he has served as Research Director and Head of the Neurovascular Unit Research and Therapeutic Innovation Laboratory. His leadership in these roles has driven breakthroughs in neurovascular research. Since 2019, Dr. Mabondzo has also been the Co-founder and Research Director of Ceres Brain Therapeutics, a startup dedicated to pioneering therapeutic innovations.

👩‍🏫 Mentoring and Supervision

Dr. Mabondzo has a proven track record as a mentor and supervisor. Over his career, he has supervised 16 PhD candidates (10 past, 6 current), 7 Postdoctoral Fellows (4 past, 3 current), and several other researchers, including 2 Research Assistants, 2 Engineers, and 2 Technicians. His mentorship has nurtured the next generation of scientists, fostering innovation and collaboration.

Publications Top Noted📄 

Dodecyl creatine ester therapy: from promise to reality

Authors: Mabondzo, A.; van de Kamp, J.; Mercimek-Andrews, S.

Journal: Cellular and Molecular Life Sciences

Year: 2024

A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases

Authors: Angeli, E.; Paris, J.; Le Tilly, O.; Paintaud, G.; Bousquet, G.

Journal: Experimental Hematology and Oncology

Year: 2024

Impaired brain glucose metabolism as a biomarker for evaluation of dodecyl creatine ester in creatine transporter deficiency: Insights from patient brain-derived organoids and in vivo [18F]FDG PET imaging in a mouse model

Authors: Disdier, C.; Soyer, A.; Broca-Brisson, L.; Tournier, N.; Mabondzo, A.

Journal: Neurobiology of Disease

Year: 2024

Targeting the Multiple Complex Processes of Hypoxia-Ischemia to Achieve Neuroprotection

Authors: Maïza, A.; Hamoudi, R.; Mabondzo, A.

Journal: International Journal of Molecular Sciences

Year: 2024

Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring

Authors: Broca-Brisson, L.; Disdier, C.; Harati, R.; Hamoudi, R.; Mabondzo, A.

Journal: Frontiers in Neuroscience

Year: 2024

Dr. Hewang Lee, Medicinal Chemistry, Outstanding Scientist Award

Posted on by sciencefather

Dr. Hewang Lee, Medicinal Chemistry, Outstanding Scientist Award

Doctorate at George Washington University, United States

Professional Profile

Scopus

Orcid

🌟 Summary

  • Dr. Lihua is a seasoned Research Scientist at George Washington University, specializing in the metabolic mechanisms of hypertension and chronic kidney diseases. With a robust background spanning prestigious institutions like NIH and Max-Planck Institute, Dr. Lihua has made significant contributions to understanding renal regulation, energy metabolism, and neuropeptide functions.

🎓 Education

  • Ph.D. in Medical Science, Beijing Medical University, 1997
  • M.S. in Medical Science, Shanghai Medical University, 1993
  • M.D. in Clinical Medicine, Bengbu Medical College, 1990

👩‍🔬 Professional Experience

  • Research Scientist, George Washington University, 2020 – Present
    • Leading projects on NPFF, SNX19, PRDX4, and autophagy in hypertension.
  • Statistical Analyst and Programmer, Rang Technologies, 2019 – 2020
    • Clinical research in oncology, cardiovascular, and renal diseases.
  • Researcher, Dalian Medical University, 2015 – 2018
    • Investigated metabolic mechanisms in chronic kidney diseases.
  • Postdoc Scientist, University of Maryland and Children National Medical Center, 2009 – 2015
    • Explored sodium reabsorption regulation and GPCR trafficking in hypertension.

🔍 Research Interests

  • Hypertension mechanisms
  • Neuropeptides and dopamine interactions
  • Autophagy and renal diseases

Publication Top Noted📝

  • Article: Poly-(ADP-ribose) polymerases inhibition by olaparib attenuates activities of the NLRP3 inflammasome and of NF-κB in THP-1 monocytes
    • Authors: Mustafa, K., Han, Y., He, D., Lee, H., Qu, P.
    • Journal: PLoS ONE
    • Volume: 19
    • Issue: 2 (February)
    • Pages: e0295837
    • Year: 2024
  • Article: Peroxiredoxin-4 and Dopamine D5 Receptor Interact to Reduce Oxidative Stress and Inflammation in the Kidney
    • Authors: Amatya, B., Yang, S., Yu, P., Lee, H., Jose, P.A.
    • Journal: Antioxidants and Redox Signaling
    • Volume: 38
    • Issue: 16
    • Pages: 1150–1166
    • Year: 2023
  • Article: RNA-Seq analysis of obese Pdha1fl/flLyz2-Cre mice induced by a high-fat diet
    • Authors: Geng, Z., Yuan, Y., He, D., Tang, Z., Qu, P.
    • Journal: Experimental Animals
    • Volume: 72
    • Issue: 1
    • Pages: 112–122
    • Year: 2023
  • Article: The Correlation between Increased Expressions of NLRP3 Inflammasome Components in Peripheral Blood Mono-Nuclear Cells and Plaque Vulnerability in Human Carotid Atherosclerosis
    • Authors: Xie, W., Shi, X., Lee, H., Niu, N., Qu, P.
    • Journal: Iranian Journal of Public Health
    • Volume: 52
    • Issue: 1
    • Pages: 147–158
    • Year: 2023
  • Article: HIV-1 Vpr suppresses expression of the thiazide-sensitive sodium chloride cotransporter in the distal convoluted tubule
    • Authors: Shrivastav, S., Lee, H., Okamoto, K., Kino, T., Kopp, J.B.
    • Journal: PLoS ONE
    • Volume: 17
    • Issue: 9 (September)
    • Pages: e0273313
    • Year: 2022

Dr. Sanjoy Chakraborty, Medicinal Chemistry, Best Researcher Award

Posted on by sciencefather

Dr. Sanjoy Chakraborty, Medicinal Chemistry, Best Researcher Award

Doctorate at New York City College of Technology, United States

Professional Profile

Scopus

Orcid

Google Scholar

🎓 Education

  • Ph.D. in Biochemistry, University of Calcutta, India
  • MS in Biochemistry and Molecular Biology, University of Calcutta, India

👨‍🏫 Professional Experience

  • Present Position: Associate Professor (Tenured), New York City College of Technology (CUNY)
  • Adjunct Professor: Suffolk County Community College
  • Previous Positions: Assistant Professor at UM-SJTU Joint Institute, Associate Professor without tenure at UM-SJTU Joint Institute, Adjunct Professor at School of Aerospace and Astronautics, Shanghai JiaoTong University

🔬 Research Interests

  • Turbulence and flow structure analysis
  • Turbulent combustion and flame dynamics
  • Fluid mechanics applications: CFD, heat transfer, flow control
  • Molecular and cell biology

🏆 Awards & Recognitions

  • Received the Chancellor’s Award for Excellence in Adjunct Teaching (SUNY) in 2017
  • Consistently rated 'Excellent' in classroom peer evaluations and independent student evaluations

👨‍🔬 Teaching Experience

  • Courses taught include Anatomy and Physiology, General Biology, Pathophysiology, Advanced Pathophysiology, Biochemistry, and Molecular Biology
  • Mentored graduate and undergraduate students in research projects

💼 Professional Contributions

  • Served on various departmental and college committees
  • Developed and co-authored courses in Molecular and Cell Biology, Biochemistry, and Pathophysiology
  • Received grants for research projects correlating obesity and reproduction, and on signaling pathways in leptin and estrogen receptors

🔗 Service to Department, College, and Community

  • Actively involved in curriculum development, web design, and safety committees
  • Served as Biology Coordinator, assisting in managing departmental responsibilities
  • Participated in Middle State Self Study and Professional Developmental Advisory Council

Notable Publication📝

  • Paper Title: Photoprotective Mechanism of the Macular Carotenoids, Lutein, and Zeaxanthin
  •                   Authors: Rasmussen HM, Johnson EJ
  •                   Journal: Archives of Biochemistry and Biophysics
  •                   Volume: 652
  •                   Issue: March 2018
  •                   Pages: 18-26
  •                   Year: 2018
  • Paper Title: Clinical Evaluation of a Novel, Patented Green Coffee Bean Extract (GCB70®)
  •                  Authors: Meroni E, et al.
  •                  Journal: Nutrients
  •                  Volume: 11
  •                  Issue: 3
  •                  Pages: 790
  •                  Year: 2019
  • Paper Title: Pathogenesis of Neurodegenerative Diseases and the Protective Role of Natural Bioactive Components
  •                   Authors: Sharma S, Kulkarni SK, Chopra K
  •                   Journal: Phytotherapy Research
  •                   Volume: 22
  •                   Issue: 12
  •                   Pages: 1562-1576
  •                   Year: 2008
  • Paper Title: Nutrition in the Pathogenesis of Metabolic Syndrome
  •                   Authors: Malik VS, Hu FB
  •                   Journal: Nature Reviews Endocrinology
  •                   Volume: 14
  •                   Issue: 7
  •                   Pages: 367-377
  •                   Year: 2018
  • Paper Title: Chemical, Microbial, and Safety Profiling of a Standardized Withania Somnifera Extract
  •                   Authors: Choudhary D, et al.
  •                   Journal: Phytotherapy Research
  •                   Volume: 32
  •                   Issue: 12
  •                   Pages: 2323-2332
  •                   Year: 2018